Trade Standard BioTools Inc - LAB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0200 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.215 |
| Open | 1.185 |
| 1-Year Change | -50.5% |
| Day's Range | 1.135 - 1.185 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 1.1450 | -0.0600 | -4.98% | 1.2050 | 1.2050 | 1.1250 |
| Apr 24, 2025 | 1.2150 | 0.0100 | 0.83% | 1.2050 | 1.2250 | 1.1950 |
| Apr 23, 2025 | 1.2250 | -0.0500 | -3.92% | 1.2750 | 1.3150 | 1.2150 |
| Apr 22, 2025 | 1.2550 | 0.0700 | 5.91% | 1.1850 | 1.2550 | 1.1850 |
| Apr 21, 2025 | 1.1950 | 0.0500 | 4.37% | 1.1450 | 1.1950 | 1.1150 |
| Apr 17, 2025 | 1.1450 | 0.0400 | 3.62% | 1.1050 | 1.1550 | 1.0950 |
| Apr 16, 2025 | 1.1250 | 0.0100 | 0.90% | 1.1150 | 1.1350 | 1.0950 |
| Apr 15, 2025 | 1.1350 | 0.0100 | 0.89% | 1.1250 | 1.1450 | 1.0950 |
| Apr 14, 2025 | 1.1350 | -0.0300 | -2.58% | 1.1650 | 1.1650 | 1.0950 |
| Apr 11, 2025 | 1.1350 | 0.0900 | 8.61% | 1.0450 | 1.1450 | 1.0450 |
| Apr 10, 2025 | 1.0850 | -0.0100 | -0.91% | 1.0950 | 1.1050 | 1.0150 |
| Apr 9, 2025 | 1.1450 | 0.1600 | 16.24% | 0.9850 | 1.1750 | 0.9750 |
| Apr 8, 2025 | 1.0250 | -0.0400 | -3.76% | 1.0650 | 1.0850 | 0.9950 |
| Apr 7, 2025 | 1.0850 | 0.1100 | 11.28% | 0.9750 | 1.1350 | 0.9650 |
| Apr 4, 2025 | 1.0550 | 0.0400 | 3.94% | 1.0150 | 1.0550 | 0.9906 |
| Apr 3, 2025 | 1.0650 | -0.0100 | -0.93% | 1.0750 | 1.1050 | 1.0650 |
| Apr 2, 2025 | 1.1650 | 0.1100 | 10.43% | 1.0550 | 1.1750 | 1.0550 |
| Apr 1, 2025 | 1.0850 | 0.0300 | 2.84% | 1.0550 | 1.1550 | 1.0550 |
| Mar 31, 2025 | 1.0750 | -0.0200 | -1.83% | 1.0950 | 1.1250 | 1.0450 |
| Mar 28, 2025 | 1.1250 | 0.0000 | 0.00% | 1.1250 | 1.1250 | 1.0650 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Standard BioTools Inc Company profile
About Fluidigm Corporation
Fluidigm Corporation creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents, and software that are used by researchers and clinical labs. The Company operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. It markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Fluidigm Corporation revenues decreased 5% to $130.6M. Net loss increased 12% to $59.2M. Revenues reflect Development revenue segment decrease of 71% to $2.6M, Instruments segment decrease of 7% to $42.5M, United States segment decrease of 16% to $60.2M, Asia-Pacific segment decrease of 7% to $24M. Higher net loss reflects Research and development increase of 4% to $37.9M (expense), Selling.
Equity composition
Common Stock $0.001 Par, 2/11, 19,938,754 auth, 19,938,754 issd. Insiders own approx. 11.14%.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
2 Tower Place
Suite 2000
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com